What is data exclusivity, and how government push may hit availability of generic drugs
India may implement data exclusivity in the pharmaceutical industry, potentially impacting the flourishing generic drug market. While it could attract more investments, it may also hinder access to affordable medicines and harm the industry's global competitiveness. Concerns arise over potential patent extensions, delayed entry of generics and monopolies on traditional medicines.